Evidence map›Paper›PMID 30806549›Full record

ArticleOphthalmic epidemiology2018

Epidemiology of trachoma and its implications for implementing the "SAFE" strategy in Somali Region, Ethiopia: results of 14 population-based prevalence surveys.

Ahmed Badei Duale, Nebiyu Negussu Ayele, Colin K Macleod, Amir Bedri Kello, Zelalem Eshetu Gezachew, Amsalu Binegdie, Michael Dejene, Wondu Alemayehu, Rebecca M Flueckiger, Patrick A Massae and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Ophthalmic epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Ahmed Badei Dualea Department of Disease Prevention , Somali Regional State Health Bureau , Jigjiga , Ethiopia.
Nebiyu Negussu Ayelea Department of Disease Prevention , Somali Regional State Health Bureau , Jigjiga , Ethiopia.
Colin K Macleodb Sightsavers , Haywards Heath , UK.
Amir Bedri Kellod Light for the World , Addis Ababa , Ethiopia.
Zelalem Eshetu Gezachewe Department of Ophthalmology , Addis Ababa University , Ethiopia.
Amsalu Binegdief Department of Ophthalmology , Gode Hospital , Gode , Ethiopia.
Michael Dejeneg Michael Dejene Public Health Consultancy Services , Addis Ababa , Ethiopia.
Wondu Alemayehuh Fred Hollows Foundation , Addis Ababa , Ethiopia.
Rebecca M Flueckigeri Task Force for Global Health , Decatur , GA , USA.
Patrick A Massaej Kilimanjaro Centre for Community Ophthalmology , Moshi , Tanzania.
Rebecca Willisi Task Force for Global Health , Decatur , GA , USA.
Biruck Kebede Negashk Ministry of Health , Addis Ababa , Ethiopia.
Anthony W Solomonc Clinical Research Department , London School of Hygiene & Tropical Medicine , London , UK.
Global Trachoma Mapping Project
The Task Force for Global Health · USAddis Ababa University · ETEthiopian Public Health Association · ETKilimanjaro Christian Medical Centre · TZLondon School of Hygiene & Tropical Medicine · GBSightsavers · GB

Funding

Medical Research Council MR/K012126/1Wellcome Trust 098521
6 · The paper itself

Abstract

purposeEthiopia is highly trachoma endemic. Baseline mapping was needed in Ethiopia's Somali Region to guide elimination efforts.

methodsCross-sectional community-based surveys were conducted in 34 suspected trachoma-endemic woredas, grouped as 14 evaluation units (EUs), using a standardised mapping methodology developed for the Global Trachoma Mapping Project.

resultsIn total, 53,467 individuals were enumerated. A total of 48,058 (89.9%) were present at the time of survey teams' visits and consented to examination. The prevalence of trachomatous inflammation-follicular (TF) among children aged 1-9 years ranged from 4.1% in the EU covering Danot, Boh, and Geladin woredas in Doolo Subzone to 38.1% in the EU covering Kebribeyah and Hareshen woredas in Fafan Subzone (East). The trichiasis prevalence among adults aged over 15

conclusionMass drug administration (MDA) with azithromycin is needed in 13 EUs (population 2,845,818). Two EUs (population 667,599) had TF prevalences in 1-9-year-olds of ≥30% and will require at least 5 years of MDA; 5 EUs (population 1,1193,032) had TF prevalences of 10-29.9% and need at least three years of MDA; 6 EUs (population 985,187) had TF prevalences of 5-9.9% and need at least one round of azithromycin distribution before re-survey. In all 13 of these EUs, implementation of facial cleanliness and environmental improvement measures is also needed. Surveys are still needed in the remaining 34 unmapped woredas of Somali Region.

Indexed as

AdolescentAdultAgedAge DistributionChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleMiddle AgedPrevalenceSex DistributionSomaliaTrachomaepidemiologyGlobal Trachoma Mapping ProjectprevalenceTrachomatrichiasis

Identifiers

PMID30806549
PMCPMC6444207
OpenAlexW2907820325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.